| __timestamp | Dr. Reddy's Laboratories Limited | Incyte Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 38783000000 | 165772000 |
| Thursday, January 1, 2015 | 42585000000 | 196614000 |
| Friday, January 1, 2016 | 45702000000 | 303251000 |
| Sunday, January 1, 2017 | 46372000000 | 366406000 |
| Monday, January 1, 2018 | 46910000000 | 434407000 |
| Tuesday, January 1, 2019 | 48890000000 | 468711000 |
| Wednesday, January 1, 2020 | 50129000000 | 516922000 |
| Friday, January 1, 2021 | 54559000000 | 739560000 |
| Saturday, January 1, 2022 | 62081000000 | 1002140000 |
| Sunday, January 1, 2023 | 105931000000 | 1161300000 |
| Monday, January 1, 2024 | 77201000000 | 1242157000 |
Unleashing the power of data
In the competitive landscape of the pharmaceutical industry, understanding the financial strategies of key players is crucial. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of Incyte Corporation and Dr. Reddy's Laboratories Limited from 2014 to 2023.
Dr. Reddy's Laboratories consistently outpaces Incyte Corporation in SG&A spending, with a staggering 1,750% higher average over the decade. Notably, Dr. Reddy's expenses peaked in 2023, reaching over 105 billion, a 70% increase from 2022. In contrast, Incyte's expenses grew steadily, peaking at 1.16 billion in 2023, marking a 600% increase since 2014.
The data suggests Dr. Reddy's aggressive market expansion and operational scale, while Incyte's growth reflects strategic investments in innovation. Missing data for 2024 indicates potential reporting delays or strategic shifts. These insights offer a window into the financial health and strategic priorities of these industry giants.
Bristol-Myers Squibb Company or Dr. Reddy's Laboratories Limited: Who Manages SG&A Costs Better?
Zoetis Inc. vs Dr. Reddy's Laboratories Limited: SG&A Expense Trends
Who Optimizes SG&A Costs Better? Regeneron Pharmaceuticals, Inc. or Dr. Reddy's Laboratories Limited
Genmab A/S and Incyte Corporation: SG&A Spending Patterns Compared
Breaking Down SG&A Expenses: Incyte Corporation vs Pharming Group N.V.
SG&A Efficiency Analysis: Comparing Incyte Corporation and ADMA Biologics, Inc.
Operational Costs Compared: SG&A Analysis of Incyte Corporation and Merus N.V.
Who Optimizes SG&A Costs Better? Incyte Corporation or Travere Therapeutics, Inc.
Incyte Corporation and MiMedx Group, Inc.: SG&A Spending Patterns Compared
Dr. Reddy's Laboratories Limited and Arrowhead Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
SG&A Efficiency Analysis: Comparing Dr. Reddy's Laboratories Limited and Iovance Biotherapeutics, Inc.
Dr. Reddy's Laboratories Limited or Xencor, Inc.: Who Manages SG&A Costs Better?